Archive

Presentation at the Global Maternal Newborn Health Conference, October 21, 2015 Background: Maternal death surveillance and response (MDSR), promotes routine identification of maternal deaths linking health information system and quality improvement…

Presentation at the Global Maternal Newborn Health Conference, October 21, 2015 In India, maternal death review provides detailed information on various factors at community and facility levels that influence maternal health outcomes. A key challenge is…

Presentation at the Global Maternal Newborn Health Conference, October 20, 2015 Background: Despite the evidence that magnesium sulfate ( MgSO4) is the drug of choice for managing severe pre-eclampsia and eclampsia (SPE/E), its usage seems low in limited…

Presentation at the Global Maternal Newborn Health Conference, October 20, 2015 Background: Calcium consumption during pregnancy reduces the incidence of pre-eclampsia/eclampsia among women with low calcium intake. Nepal implemented a pilot program to…

Presentation at the Global Maternal Newborn Health Conference, October 20, 2015 Preeclampsia/eclampsia (PE/E) causes around 40% of maternal deaths in some Nigerian states. Although magnesium sulphate (MgSO4) has been available in Nigeria during the last…

Presentation at the Global Maternal Newborn Health Conference, October 19, 2015 Background: Pre-eclampsia remains a leading cause of maternal and perinatal morbidity and mortality. Of the 5-600,000 maternal and perinatal lives lost to pre-eclampsia…

Course: The Evidence-Based Management of Pre-Eclampsia/Eclampsia Source: Maternal Health Task Force, EngenderHeath, MacArthur Foundation, Nuffield Department of Obstetrics and Gynaecology at the University of Oxford, Geneva Foundation for Medical…